미래메디엔텍

비상장계속사업자

MIRAE MEDI AND TECH CO LTD

박정훈

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

미래메디엔텍

Business Reg. No. 1058733980 · CEO 박정훈

I.Investment Overview

Target미래메디엔텍 (1058733980)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명미래메디엔텍
영문명MIRAE MEDI AND TECH CO LTD
대표자박정훈
사업자등록번호1058733980
법인등록번호1101114141993
설립일2009.07.21

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW311.52021192.52022127.12023170.22024145.72025
영업이익100M KRW24.2202124.9202224.2202328.8202422.92025
순이익100M KRW23.1202115.4202220.2202320.22024122025
Item20252024202320222021
자산총계254.2억원287.4억원309.7억원324.7억원277.5억원
부채총계141.8억원177.1억원209.6억원234.8억원197.9억원
자본총계112.4억원110.3억원100.1억원90억원79.6억원
매출액145.7억원170.2억원127.1억원192.5억원311.5억원
영업이익22.9억원28.8억원24.2억원24.9억원24.2억원
순이익12억원20.2억원20.2억원15.4억원23.1억원

VI.Financial Ratios

FY2025 basis

15.69%

영업이익률

8.25%

순이익률

4.73%

ROA

10.7%

ROE

126.23%

부채비율

44.2%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

미래메디엔텍 투심보고서 | Alpha Lenz